EGFR and metastatic neoplasm: Indeed, some reports in lung cancer have demonstrated discordant mutation patterns between primary and metastatic tumors and a heterogeneous distribution of epidermal growth factor receptor (EGFR) mutations in individual tumors [22]–[25].